コンテンツへスキップ
Merck
  • Synthesis, evaluation and docking studies on 3-alkoxy-4-methanesulfonamido acetophenone derivatives as non ulcerogenic anti-inflammatory agents.

Synthesis, evaluation and docking studies on 3-alkoxy-4-methanesulfonamido acetophenone derivatives as non ulcerogenic anti-inflammatory agents.

European journal of medicinal chemistry (2012-02-10)
Alka Bali, Ruchika Ohri, Pran Kishore Deb
要旨

A series of 3-alkoxy-4-methanesulfonamido acetophenone derivatives were synthesized and evaluated for their anti-inflammatory activity in carrageenan-induced rat paw edema model. The synthesized compounds were also investigated for their gastric ulcerogenic potential. The compounds 4a, 4c and 4d showed comparable anti-inflammatory activity to rofecoxib and indomethacin, the standard drugs taken in both studies and were also non ulcerogenic at the test doses. In silico (docking studies) were done to investigate the hypothetical binding mode of the target compounds to the cyclooxygenase isoenzyme (COX-2). A binding model has been proposed based on the docking studies. Selected physicochemical properties were calculated for theoretical ADME profiling of the compounds and excellent compliance was shown with Lipinski's rules.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
インドメタシン, 98.5-100.5% (in accordance with EP)
Sigma-Aldrich
アセトフェノン, ≥98%, FG
Sigma-Aldrich
メタンスルホンアミド, ≥97.0% (CHN)
Sigma-Aldrich
インドメタシン, meets USP testing specifications
Sigma-Aldrich
アセトフェノン, ReagentPlus®, 99%
Supelco
アセトフェノン, analytical standard
Sigma-Aldrich
アセトフェノン, puriss. p.a., ≥99.0% (GC)